Premier closes in on big MRI purchase

Article

Group purchasing organization Premier is in the final weeks of a massive group buy of MRI equipment that could total over $100 million. GE Medical Systems of Milwaukee and Siemens Medical Systems of Iselin, NJ, are beneficiaries of the purchasing, which

Group purchasing organization Premier is in the final weeks of a massive group buy of MRI equipment that could total over $100 million. GE Medical Systems of Milwaukee and Siemens Medical Systems of Iselin, NJ, are beneficiaries of the purchasing, which must be finalized by Dec. 31.

The group purchase is part of Premier's strategy of securing price discounts for its members by negotiating large sole-source or dual-source acquisitions. Premier members participating in the group buy must purchase from either GE or Siemens, according to Pam Parker, director of group buys for San Diego-based Premier.

Some 88 Premier members had asked to participate in the group purchase as of mid-December, and more may sign on by the time the deadline expires, Parker said. Premier expects that about 85% of those hospitals will end up buying equipment, bringing the total value of the sale to over $100 million. The deal will be the largest group buy in Premier's history, besting an $87 million group buy of GE and Philips cardiac and vascular x-ray rooms completed earlier this year.

The deal's large size is due to high interest among Premier members in new MRI technology, such as short-bore and open-bore magnets, Parker said. A large number of hospitals are replacing older magnets purchased seven or eight years ago, she said.

Siemens is offering all four of its MRI magnets through the group buy, according to Joe Camaratta, division manager for MRI at Siemens. The vendor expects most of the acquisitions to occur in December, as many Premier members put off their decision until they could view the latest technology at this month's Radiological Society of North America meeting.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.